Pharma should eye Latin America, says PwC

Monday, May 9, 2005

Latin America shows considerable and untapped business potential for the pharmaceutical industry, according to new research conducted by PricewaterhouseCoopers.
The report, entitled Latin America Prescription for Growth, identifies the region as one pharmaceutical industry leaders should be targeting, both as an area for research and development and as a market for innovative drugs.
The economic recovery of Argentina and Brazil and the strong manufacturing base developing in Mexico are all making Latin America much more appealing as a place in which to conduct development and production, according to PwC.
And the market is showing strong scope for growth. The United Nations projects the overall population of the region will increase by about 23 per cent over the next 20 years, from 504 million to 623 million, and mortality rates for cancer, heart disease and strokes and the incidence of diabetes are all increasing as a result of more sedentary lifestyles, smoking, drinking and obesity.
Story found here.

Source: in-Pharma